2019 annual financial data

Sarepta Therapeutics, Inc. 2019 Operating margin

Sarepta Therapeutics, Inc. 2019 operating margin with verified reported values.

Direct answer

Operating margin was -185.27%.

Operating income was -705,563,000 USD and net income was -715,075,000 USD.
Operating cash flow was -456,463,000 USD.

Get free Sarepta Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
380,833,000 USD
Operating income
-705,563,000 USD
Net income
-715,075,000 USD
Operating cash flow
-456,463,000 USD